Silvia Mezi
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Surgery
- Co-authors
- Alberto ZaniboniElisa SensiAlfredo FalconeMarina Elena CazzanigaFotios LoupakisCristina GranettoGiuseppe ToniniChiara Cremolini
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)Head and Neck Cancer Studies (8 papers)Medical Imaging Techniques and Applications (5 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Silvia Mezi
47 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 416
- Pathology and Forensic Medicine 292
- Molecular Biology 252
- Surgery 240
Countries citing papers authored by Silvia Mezi
This map shows the geographic impact of Silvia Mezi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Mezi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Mezi more than expected).
Fields of papers citing papers by Silvia Mezi
This network shows the impact of papers produced by Silvia Mezi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Mezi. The network helps show where Silvia Mezi may publish in the future.
Co-authorship network of co-authors of Silvia Mezi
This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Mezi. A scholar is included among the top collaborators of Silvia Mezi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Mezi. Silvia Mezi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | 0 | |
| 6 | 12 | |
| 7 | 1 | |
| 8 | 14 | |
| 9 | 2 | |
| 10 | 67 | |
| 11 | 29 | |
| 12 | 18 | |
| 13 | 34 | |
| 14 | 13 | |
| 15 | 1 | |
| 16 | FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE studybreakdown → | 733 |
| 17 | 51 | |
| 18 | 30 | |
| 19 | 20 | |
| 20 | 1 |
About Silvia Mezi
Silvia Mezi is a scholar working on Otorhinolaryngology, Oncology and Biological Psychiatry, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Head and Neck Cancer Studies (8 papers) and Medical Imaging Techniques and Applications (5 papers). The work is most often cited by research in Oncology (1.0k citations), Hepatology (222 citations) and Otorhinolaryngology (106 citations). Silvia Mezi has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Alberto Zaniboni, Elisa Sensi, Alfredo Falcone, Marina Elena Cazzaniga, Fotios Loupakis, Cristina Granetto, Giuseppe Tonini, Chiara Cremolini, Giacomo Allegrini and Cristiana Lupi. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.